Lipids and Alzheimer's Disease.

Kao YC, Ho PC, Tu YK, Jou IM, Tsai KJ. · 2020

Read Lipids and Alzheimer's Disease. by Kao YC, Ho PC, Tu YK, Jou IM, Tsai KJ. (2020) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc7073164.txt.

Description

Kao and co-authors review lipids in Alzheimer's disease in the International Journal of Molecular Sciences. Lipids build every cell membrane, and the brain is unusually rich in them. When lipid balance breaks down, neurological disease can follow. Alzheimer's is the commonest dementia: about 46.8 million people lived with dementia worldwide in 2015, with an estimated 9.9 million new cases each year.

Ageing itself shifts the brain's lipid mix. Changes in fatty acids inside membrane rafts and oxidation of brain lipids appear early in Alzheimer's. Genes for apolipoprotein and lipid transporters alter risk, and so does the fat content of the diet. New analytical methods have opened lipidomics, the full census of lipids, as a hunting ground for markers that predict, diagnose, or help prevent the disease. The review gathers what is known about each lipid family in Alzheimer's, from membrane phospholipids to signalling fats, aiming toward new therapeutics.

Catalog record

CREATORKao YC, Ho PC, Tu YK, Jou IM, Tsai KJ.
YEAR2020
COLLECTIONPAPERS
FORMATTXT
FILE SIZE145 KB
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC7073164

Browse the full library · About the Tower of Babel